- The stock price of Enveric Biosciences Inc (NASDAQ: ENVB) is trading higher today. This is why it happened.
The stock price of Enveric Biosciences Inc (NASDAQ: ENVB) – a patient-first biotechnology company developing novel cannabinoid medicines to improve the quality of life for cancer patients – is trading higher today. Investors are responding positively to Enveric Biosciences announcing that Dr. Joseph Tucker, MagicMed Industries’ Chief Executive Officer, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference and Virtual Gravitas Health Reimagined Investor Day.
Dr. Tucker’s H.C. Wainwright 23rd Annual Global Investment Conference presentation is going to be available on-demand starting Monday, September 13th at 7:00 a.m. ET. And Dr. Tucker is also scheduled to present on Thursday, September 16th at 10:00 a.m. PT / 1:00 p.m. ET at the Virtual Gravitas Health Reimagined Investor Day.
On May 24, Enveric Biosciences had announced the definitive agreement to buy MagicMed Industries. And Enveric and MagicMed will each hold a meeting of their respective stockholders. The Enveric annual meeting will be held virtually on September 14, 2021 at 10:00 a.m. ET.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.